Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Eisai
Company Monitoring Page for Eisai
latest headlines for company on cafepharma
Despite recent approvals, significant unmet need remains in Alzheimer’s market
Clinical Trials Arena
Wed, 03/1/23 - 10:05 am
Tags:
Alzheimer's disease
,
Biogen
,
Eisai
,
Lundbeck
,
Otsuka
,
Avanir Pharmaceuticals
,
Axesome
,
Aduhelm
,
Leqembi
Medicare maintains limits on Eisai’s new Alzheimer’s drug
BioPharma Dive
Thu, 02/23/23 - 04:27 pm
Tags:
Medicare
,
CMS
,
Eisai
,
Biogen
,
Leqembi
,
Alzheimer's disease
Eisai Anticipates Full Approval of Leqembi as Early as July
BioSpace
Mon, 02/20/23 - 12:44 pm
Tags:
Eisai
,
FDA
,
Alzheimer's disease
,
Leqembi
,
lecanemab
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
Thu, 02/16/23 - 11:18 am
Tags:
layoffs
,
Grifols
,
Frequency Therapeutics
,
Eliem Therapeutics
,
Aligos Therapeutics
,
Thermo Fisher Scientific
,
Magenta Therapeutics
,
Eisai
,
Amgen
,
Y-mAbs Therapeutics
,
Century Therapeutics
,
Elevation Oncology
,
Calithera Biosciences
,
Editas Medicine
,
Verily
,
Abzena
Eisai gives first glimpse into Alzheimer’s drug launch
BioPharma Dive
Mon, 02/6/23 - 06:21 pm
Tags:
Eisai
,
Alzheimer's disease
,
drug launches
,
Leqembi
With all eyes on new Alzheimer's med, Eisai lays off 91 staffers on its Fycompa team
Fierce Pharma
Fri, 02/3/23 - 11:03 am
Tags:
Eisai
,
Fycompa
,
layoffs
Why Biogen's Stock Isn't Soaring Since Its Alzheimer's Drug Got Approval
Motley Fool
Thu, 01/19/23 - 10:15 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
Leqembi
,
lecanemab
Alzheimer’s disease trials: How does Lilly’s donanemab compare to lecanemab?
Clinical Trials Arena
Fri, 01/13/23 - 10:49 am
Tags:
clinical trials
,
Alzheimer's disease
,
Eisai
,
Biogen
,
Eli Lilly
,
Leqembi
,
lecanemab
,
donanemab
After FDA nod, Eisai and Biogen file lecanemab in EU
Pharmaphorum
Wed, 01/11/23 - 11:04 pm
Tags:
Eisai
,
Biogen
,
lecanemab
,
Europe
,
Alzheimer's disease
Eisai learns from Biogen’s Aduhelm disaster
EP Vantage
Mon, 01/9/23 - 10:35 am
Tags:
Eisai
,
Biogen
,
Leqembi
,
Aduhelm
,
Alzheimer's disease
,
drug pricing
Eisai, in pricing new Alzheimer’s drug, tries to sidestep controversy
BioPharma Dive
Sun, 01/8/23 - 10:04 pm
Tags:
Eisai
,
Biogen
,
drug pricing
,
Leqembi
,
Alzheimer's disease
,
lecanemab
FDA approves Alzheimer’s drug from Eisai, Biogen in closely watched decision
BioPharma Dive
Fri, 01/6/23 - 03:40 pm
Tags:
Eisai
,
Biogen
,
lecanemab
,
Leqembi
,
Alzheimer's disease
,
FDA
Eisai and Biogen’s latest Alzheimer’s drug needs to be cheaper than the last one, analysts say
Stat
Thu, 12/22/22 - 11:10 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
drug pricing
,
ICER
,
lecanemab
3rd patient death potentially tied to Eisai's Alzheimer's drug reported
Fierce Biotech
Thu, 12/22/22 - 11:05 am
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
clinical trials
,
patient deaths
,
lecanemab
With bigger fish to fry, Eisai unloads US rights to epilepsy drug Fycompa to Catalyst
Fierce Pharma
Tue, 12/20/22 - 11:14 am
Tags:
Eisai
,
Fycompa
,
Catalyst Pharmaceuticals
,
epilepsy
CTAD 2022 – lecanemab data hold up, with a big but
EP Vantage
Thu, 12/1/22 - 07:01 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
CTAD
,
lecanemab
,
clinical trials
What to make of Eisai and Biogen’s latest Alzheimer’s drug data
BioPharma Dive
Tue, 11/29/22 - 10:58 pm
Tags:
Biogen
,
Eisai
,
Alzheimer's disease
,
lecanemab
Eisai, Biogen rocked by 2nd lecanemab death report ahead of Alzheimer's data reveal
Fierce Biotech
Mon, 11/28/22 - 07:51 pm
Tags:
Biogen
,
Eisai
,
clinical trials
,
patient death
,
lecanemab
,
Alzheimer's disease
Lilly powers through final stretch in critical Alzheimer's race
Fierce Biotech
Tue, 11/1/22 - 07:02 pm
Tags:
Eli Lilly
,
Alzheimer's disease
,
donanemab
,
lecanemab
,
Eisai
Eisai's Alzheimer's hopeful lecanemab may have contributed to patient death: report
Fierce Biotech
Mon, 10/31/22 - 10:30 am
Tags:
Eisai
,
patient death
,
lecanemab
,
Alzheimer's disease
,
clinical trials
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.